Plumbagin alleviates temporomandibular joint osteoarthritis progression by inhibiting chondrocyte ferroptosis via the MAPK signaling pathways
Aging · 2023
DOI: 10.18632/aging.205253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Tiehan Cui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Ferroptosis, Cartilage, Articular, Osteoarthritis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
- Medical Innovation Center, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
- Department of Stomatology, Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Beijing 100039, China.
Zitieren
APA
Cui, T., Lan, Y., Yu, F., Lin, S., & Qiu, J. (2023). Plumbagin alleviates temporomandibular joint osteoarthritis progression by inhibiting chondrocyte ferroptosis via the MAPK signaling pathways. Aging. https://doi.org/10.18632/aging.205253
Vancouver
Cui T, Lan Y, Yu F, Lin S, Qiu J. Plumbagin alleviates temporomandibular joint osteoarthritis progression by inhibiting chondrocyte ferroptosis via the MAPK signaling pathways. Aging. 2023. doi:10.18632/aging.205253
BibTeX
@article{Cui2023,
author = {Cui, Tiehan and Lan, Yun and Yu, Fei and Lin, Suai and Qiu, Jiaxuan},
title = {Plumbagin alleviates temporomandibular joint osteoarthritis progression by inhibiting chondrocyte ferroptosis via the MAPK signaling pathways},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205253}
}
EUVIMED